References
Dasari A, Shen C, Halperin D et al. Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States. JAMA Oncol. 2017; 3: 1335–42.
Trikalinos NA, Chatterjee D, Lee J et al. Accuracy of grading in pancreatic neuroendocrine neoplasms and effect on survival estimates. An institutional experience. Ann Surg Oncol. 2020. https://doi.org/10.1245/s10434-020-08377-x.
Scarpa A, Chang DK, Nones K et al. Whole-genome landscape of pancreatic neuroendocrine tumours. Nature. 2017; 543: 65–71.
Di Domenico A, Wiedmer T, Marinoni I, Perren A. Genetic and epigenetic drivers of neuroendocrine tumours (NET). Endocr Relat Cancer. 2017; 24: R315–34.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosures
The authors have no conflicts of interest to disclose.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Trikalinos, N.A., Chatterjee, D. ASO Author Reflections: Accuracy of Grading in Pancreatic Neuroendocrine Neoplasms and Effect on Survival Estimates: An Institutional Experience. Ann Surg Oncol 27, 3551–3552 (2020). https://doi.org/10.1245/s10434-020-08424-7
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-020-08424-7